The Veteran's initial rating for residual of squamous cell carcinoma was granted at 80 percent, and the effective date for TDIU and special monthly compensation was also granted as January 26, 2022.
The deciding factor: The evidence showed that the Veteran had a documented history of recurrent or refractory esophageal stricture causing dysphagia with substantial weight loss and treatment by a feeding tube, which met the criteria for an 80 percent rating under the revised diagnostic code effective May 19, 2024.
- Claimed conditions
- Residual of squamous cell carcinoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 80%
- Decision date
- October 31, 2024
- Citation
- A24070874
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
- Remanded (sent back)
The Board remands the claim for a rating in excess of 70 percent for PTSD due to an inadequate medical opinion.
- Granted
The Board granted service connection for myasthenia gravis based on the Veteran's exposure to hazardous substances during his military service.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.